{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:36:37Z","timestamp":1777102597934,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00467-024-06543-x","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T03:41:06Z","timestamp":1728531666000},"page":"865-872","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IPNA consensus definitions for clinical trial outcomes in steroid-resistant nephrotic syndrome"],"prefix":"10.1007","volume":"40","author":[{"given":"Pankaj","family":"Hari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Bhimma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Christian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Duzova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Gyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Safouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Smoyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the IPNA Best Practices and Standards Committee and c4c Pediatric Nephrology Expert Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"6543_CR1","doi-asserted-by":"crossref","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Executive Group on behalf of the Joint European Society of Cardiology \/American College of Cardiology\/American Heart Association\/World Heart Federation Task Force for the Universal Definition of Myocardial Infarction (2018) Fourth universal definition of myocardial infarction. Circulation 138:e618 e651","DOI":"10.1161\/CIR.0000000000000617"},{"key":"6543_CR2","doi-asserted-by":"crossref","unstructured":"Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee JM, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV; American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 44:2064\u20132089","DOI":"10.1161\/STR.0b013e318296aeca"},{"key":"6543_CR3","doi-asserted-by":"crossref","unstructured":"Levin A, Agarwal R, Herrington WG, Heerspink HL, Mann JFE, Shahinfar S, Tuttle KR, Donner JA, Jha V, Nangaku M, de Zeeuw D, Jardine MJ, Mahaffey KW, Thompson AM, Beaucage M, Chong K, Roberts GV, Sunwold D, Vorster H, Warren M, Damster S, Malik C, Perkovic V, Participant authors of the International Society of Nephrology\u2019s 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials (2020) International consensus definitions of clinical trial outcomes for kidney failure: 2020. Kidney Int 98:849\u2013859","DOI":"10.1016\/j.kint.2020.07.013"},{"key":"6543_CR4","doi-asserted-by":"crossref","unstructured":"Veltkamp F, Rensma LR, Bouts AHM, LEARNS Consortium (2021) Incidence and relapse of idiopathic nephrotic syndrome: Meta-analysis. Pediatrics 148:e2020029249","DOI":"10.1542\/peds.2020-029249"},{"key":"6543_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha A, Hari P, Sharma PK, Gulati A, Kalaivani M, Mantan M, Dinda AK, Srivastava RN, Bagga A (2012) Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr 49:881\u2013887","journal-title":"Indian Pediatr"},{"key":"6543_CR6","doi-asserted-by":"crossref","unstructured":"Trautmann A, Vivarelli M, Samuel S, Gipson D, Sinha A, Schaefer F, Hui NK, Boyer O, Saleem MA, Feltran L, Muller-Deile J, Becker JU, Cano F, Xu H, Lim YN, Smoyer W, Anochie I, Nakanishi K, Hodson E, Haffner D; International Pediatric Nephrology Association (2020) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 35:1529\u20131561","DOI":"10.1007\/s00467-020-04519-1"},{"key":"6543_CR7","doi-asserted-by":"crossref","unstructured":"Dyer AR, Greenland P, Elliott P, Daviglus ML, Claeys G, Kesteloot H, Ueshima H, Stamler J, Intermap Research Group (2004) Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol 160:1122\u20131131","DOI":"10.1093\/aje\/kwh326"},{"key":"6543_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"J Radhakrishnan","year":"2012","unstructured":"Radhakrishnan J, Cattran DC (2012) The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2013application to the individual patient. Kidney Int 82:840\u2013856","journal-title":"Kidney Int"},{"key":"6543_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/aje\/kwj271","volume":"164","author":"RT Gansevoort","year":"2006","unstructured":"Gansevoort RT, Brinkman J, Bakker SJ, De Jong PE, de Zeeuw D (2006) Evaluation of measures of urinary albumin excretion. Am J Epidemiol 164:725\u2013727","journal-title":"Am J Epidemiol"},{"key":"6543_CR10","doi-asserted-by":"publisher","first-page":"101240","DOI":"10.1016\/j.eclinm.2021.101240","volume":"43","author":"P Ruggenenti","year":"2022","unstructured":"Ruggenenti P, Kraus BJ, Inzucchi SE, Zinman B, Hantel S, Mattheus M, von Eynatten M, Remuzzi G, Koitka-Weber A, Wanner C (2022) Nephrotic-range proteinuria in type 2 diabetes: effects of empagliflozin on kidney disease progression and clinical outcomes. EClinicalMedicine 43:101240","journal-title":"EClinicalMedicine"},{"key":"6543_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1464-5491.2000.00200.x","volume":"17","author":"CJ Schultz","year":"2000","unstructured":"Schultz CJ, Dalton RN, Turner C, Neil HA, Dunger DB (2000) Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study Group. Diabet Med 17:7\u201314","journal-title":"Diabet Med"},{"key":"6543_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0272-6386(03)00023-4","volume":"41","author":"BZ Morgenstern","year":"2003","unstructured":"Morgenstern BZ, Butani L, Wollan P, Wilson DM, Larson TS (2003) Validity of protein-osmolality versus protein-creatinine ratios in the estimation of quantitative proteinuria from random samples of urine in children. Am J Kidney Dis 41:760\u2013766","journal-title":"Am J Kidney Dis"},{"key":"6543_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/ajcp\/100.4.419","volume":"100","author":"DM Wilson","year":"1993","unstructured":"Wilson DM, Anderson RL (1993) Protein-osmolality ratio for the quantitative assessment of proteinuria from a random urinalysis sample. Am J Clin Pathol 100:419\u2013424","journal-title":"Am J Clin Pathol"},{"key":"6543_CR14","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.kint.2016.06.020","volume":"90","author":"MC Hogan","year":"2016","unstructured":"Hogan MC, Reich HN, Nelson PJ, Adler SG, Cattran DC, Appel GB, Gipson DS, Kretzler M, Troost JP, Lieske JC (2016) The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases. Kidney Int 90:1080\u20131089","journal-title":"Kidney Int"},{"key":"6543_CR15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2215\/CJN.11971116","volume":"12","author":"DY Fuhrman","year":"2017","unstructured":"Fuhrman DY, Schneider MF, Dell KM, Blydt-Hansen TD, Mak R, Saland JM, Furth SL, Warady BA, Moxey-Mims MM, Schwartz GJ (2017) Albuminuria, proteinuria, and renal disease progression in children with CKD. Clin J Am Soc Nephrol 12:912\u2013920","journal-title":"Clin J Am Soc Nephrol"},{"key":"6543_CR16","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa2308550","volume":"389","author":"MN Rheault","year":"2023","unstructured":"Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H, DUPRO Steering Committee and DUPLEX Investigators (2023) Sparsentan versus irbesartan in Focal segmental glomerulosclerosis. N Engl J Med 389:2436\u20132445","journal-title":"N Engl J Med"},{"key":"6543_CR17","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","volume":"99","author":"CB Pierce","year":"2021","unstructured":"Pierce CB, Munoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948\u2013956","journal-title":"Kidney Int"},{"key":"6543_CR18","unstructured":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276"},{"key":"6543_CR19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/ki.2011.195","volume":"80","author":"DS Gipson","year":"2011","unstructured":"Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D\u2019Agati VD, Friedman AL (2011) Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 80:868\u2013878","journal-title":"Kidney Int"},{"key":"6543_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2215\/CJN.04780517","volume":"13","author":"JP Troost","year":"2018","unstructured":"Troost JP, Trachtman H, Nachman PH, Kretzler M, Spino C, Komers R, Tuller S, Perumal K, Massengill SF, Kamil ES, Oh G, Selewski DT, Gipson P, Gipson DS (2018) An outcomes-based definition of proteinuria remission in focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 13:414\u2013421","journal-title":"Clin J Am Soc Nephrol"},{"key":"6543_CR21","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1681\/ASN.2016101121","volume":"28","author":"A Trautmann","year":"2017","unstructured":"Trautmann A, Schnaidt S, Lipska-Zietkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F, PodoNet Consortium (2017) Long-term outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol 28:3055\u20133065","journal-title":"J Am Soc Nephrol"},{"key":"6543_CR22","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1681\/ASN.2018010091","volume":"29","author":"H Trachtman","year":"2018","unstructured":"Trachtman H, Nelson P, Adler S, Campbell KN, Chaudhuri A, Derebail VK, Gambaro G, Gesualdo L, Gipson DS, Hogan J, Lieberman K, Marder B, Meyers KE, Mustafa E, Radhakrishnan J, Srivastava T, Stepanians M, Tesar V, Zhdanova O, Komers R; DUET Study Group (2018) DUET: A phase 2 study evaluating the efficacy and safety of sparsentan in patients with FSGS. J Am Soc Nephrol 29:2745\u20132754","journal-title":"J Am Soc Nephrol"},{"key":"6543_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/ki.2012.238","volume":"82","author":"A Gulati","year":"2012","unstructured":"Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A (2012) Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome. Kidney Int 82:1130\u20131135","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06543-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T10:21:46Z","timestamp":1737368506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06543-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6543"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06543-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OB provides scientific advice or participates in sponsored clinical trials for Alexion, Alnylam, Biocodex, Bristol-Myers Squibb, Glaxo Smith Kline, Purespring, Roche, Sanofi, Takeda, Travere\/CSL\/Vifor. MV has participated in sponsored clinical trials, provided consulting, participated in advisory boards, or given sponsored lectures for Novartis, Roche, Apellis, Alexion, Vifor, Glaxo, Chinook, Bayer, Biocryst, Travere, Pure Spring. FS has received consulting fees from Roche, Stada, and Bayer and research support from Novartis.The above activities do not influence the content of the current manuscript for all authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}